Locations:
Search
TNFRSF1B gene variant associated with slower progression, offering potential drug target
Clinical cohort study helps define red flags for these rare MS mimics
Researchers develop a personalized genomic medicine platform to identify clinically actionable mutations
5 scenarios in which you should consider cancer predisposition
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Research consortium launches multisite investigations of the impact of aberrant immunity
How the new collaboration is improving patient outcomes
Largest-to-date evaluation of germline mutations in this population demonstrates the value of genetics evaluation and genetic testing
Meet the Director of Cleveland Clinic’s new Center for Immunotherapy and Precision Immuno-Oncology
Screening assay effective across all stages, can identify tissue of origin
Copy number variants may help predict clinical outcomes
Advertisement
Advertisement